Therapeutic effects of magnetic and copper bracelets in osteoarthritis: A randomised placebo-controlled crossover trial

Complementary Therapies in Medicine

Volumn 17, Issue 5-6, 2009, Pages 249-256

  Richmond, Stewart J ^a   Brown, Sally R ^b   Campion, Peter D ^c   Porter, Amanda J L ^d   Moffett, Jennifer A Klaber ^e   Jackson, David A ^e   Featherstone, Valerie A ^c   Taylor, Andrew J ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d NHS Hull   (United Kingdom)

^e Institute of Rehabilitation   (United Kingdom)

Author keywords

Copper; Magnetics; Osteoarthritis; Pain

Indexed keywords

CODEINE; COPPER; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAGNETOTHERAPY; MALE; MCGILL PAIN QUESTIONNAIRE; MUSCULOSKELETAL STIFFNESS; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; COPPER; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENGLAND; FEMALE; HUMANS; JEWELRY; MAGNETICS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WRIST;

EID: 70449710832     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2009.07.002     Document Type: Article

References (26)

1. Mourino M.R. From Thales to Lauterbur, or from the lodestone to MR imaging: magnetism and medicine. Radiology 180 3 (1991) 593-612
2. Basford J.R. A historical perspective of the popular use of electric and magnetic therapy. Arch Phys Med Rehabil 82 9 (2001) 1261-1269
3. Herr H.W. Franklin, Lavoisier, and Mesmer: origin of the controlled clinical trial. Urol Oncol 23 5 (2005) 346-351
4. Ratterman R., Secrest J., Norwood B., and Ch'ien A.P. Magnet therapy: what's the attraction?. J Am Acad Nurse Pract 14 8 (2002) 347-353
5. WHO. The burden of musculoskeletal conditions at the start of the new millennium: report of a WHO Scientific Group (2003), World Health Organisation, Geneva
6. Quandt S.A., Chen H., Grzywacz J.G., Bell R.A., Lang W., and Arcury T.A. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis Rheum 53 5 (2005) 748-755
7. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 279 19 (1998) 1548-1553
8. Wider B., and Ernst E. CAM research funding in the UK: surveys of medical charities in 1999 and 2002. Complement Ther Med 11 3 (2003) 165-167
9. Pittler M.H., Brown E.M., and Ernst E. Static magnets for reducing pain: systematic review and meta-analysis of randomized trials. CMAJ 177 7 (2007) 736-742
10. Arden N., and Nevitt M.C. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 20 1 (2006) 3-25
11. Wolsko P.M., Eisenberg D.M., Simon L.S., Davis R.B., Walleczek J., Mayo-Smith M., et al. Double-blind placebo-controlled trial of static magnets for the treatment of osteoarthritis of the knee: results of a pilot study. Altern Ther Health Med 10 2 (2004) 36-43
12. Harlow T., Greaves C., White A., Brown L., Hart A., and Ernst E. Randomised controlled trial of magnetic bracelets for relieving pain in osteoarthritis of the hip and knee. BMJ 329 7480 (2004) 1450-1454
13. Hinman M.R., Ford J., and Heyl H. Effects of static magnets on chronic knee pain and physical function: a double-blind study. Altern Ther Health Med 8 4 (2002) 50-55
14. Finegold L., and Flamm B.L. Magnet therapy. BMJ 332 7532 (2006) 4
15. Canter P.H. Blinding optimism attracts magnet researchers to the wrong conclusion. Focus Altern Complement Ther 10 3 (2005) 217-218
16. Greaves C.J., and Harlow T.N. Exploration of the validity of weak magnets as a suitable placebo in trials of magnetic therapy. Complement Ther Med 16 (2008) 177-180
17. Walker W.R., and Keats D.M. An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions Suppl 6 4 (1976) 454-459
18. Walker W.R., Beveridge S.J., and Whitehouse M.W. Dermal copper drugs: the copper bracelet and Cu(II) salicylate complexes. Agents Actions Suppl 8 (1981) 359-367
19. Richmond S.J. Magnet therapy for the relief of pain and inflammation in rheumatoid arthritis (CAMBRA): a randomised placebo-controlled crossover trial. Trials 9 (2008) 53
20. Shackel N.A., Day R.O., Kellett B., and Brooks P.M. Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial. Med J Aust 167 3 (1997) 134-136
21. Colbert A.P., Markov M.S., and Souder J.S. Static magnetic field therapy: dosimetry considerations. J Altern Complement Med 14 5 (2008) 577-582
22. Senn S. Crossover trials in clinical research (2002), John Wiley & Sons Ltd, Chichester
23. Vickers A. How to reduce the number of patients needed for randomized trials: a basic introduction. Complement Ther Med 9 4 (2001) 234-236
24. Erdfelder E., Faul F., and Buchner A. GPOWER: a general power analysis program. Behav Res Methods Instrum Comp 28 (1996) 1-11
25. Angst F., Aeschlimann A., and Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 45 4 (2001) 384-391
26. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 64 1 (2005) 29-33